While advancements in diagnostics are promising, the need remains for healthcare professionals to take the lead on proactive conversations with patients and their loved ones about the early signs ...

The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a ...

From L-R: Quibim COO Alberto Valiente, CEO Ángel Alberich-Bayarri, VP Finance & Business Intelligence Javier Sáez. Photo by Quibim, S.L. As the saying goes, a picture is worth 1,000 words.

Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the products in this drug class only address liver proteins.

Many independent pharmacists may decide or have already decided not to carry drugs in the Medicare Drug Price Negotiation Program due to financial challenges, the National Community Pharmacists ...

In the quiet corners of healthcare, there’s a conversation that needs to be had. It’s a conversation about hospice — a critical yet often misunderstood part of end-of-life care. Many ...

Specialty care platform Lantern has launched an exclusive partnership with Pelago, a digital clinic for substance use management, the companies announced last week. Dallas, Texas-based Lantern ...

Reflecting on the healthcare industry’s first year of mandatory hybrid measure submissions, I’m reminded of a fundamental truth I’ve learned over my three decades in healthcare leadership ...

An Akero Therapeutics drug in development for the fatty liver disease MASH now has clinical trial results showing the experimental treatment reversed organ scarring, bringing patients back from an ...

ICHRAs are gaining a lot of interest in healthcare. Some say they are beneficial because they give employees more choice in their health insurance, while others are more skeptical.

Finalists for the diagnostics track at INVEST Pitch Perfect include tests for upper respiratory infections, breast cancer screening, in vitro cellular immunoassays, dysphagia diagnostics, and ...